Larvol Delta - Oncotelic-Announces-Successful-Completion-of-the-Safety-Evaluation-of-a-TGF-Inhibitor-OT101-and-IL2-Aldesleukin-in-Phase-1-Combination-Trial-in-Solid-Tumor-Cancers

trabedersen (OT-101) - Autotelic, Oncotelic

https://www.globenewswire.com/news-release/2021/11/16/2335309/0/en/Oncotelic-Announces-Successful-Completion-of-the-Safety-Evaluation-of-a-TGF-%CE%B2-Inhibitor-OT-101-and-IL-2-Aldesleukin-in-Phase-1-Combination-Trial-in-Solid-Tumor-Cancers.html

Nov 16, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next